Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.
How the FDA and CMS worked together on a new approach to paying for digital mental health treatments
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...
I'm one of many people, I'm sure, who've been blindsided by IRMAA. I'm trying to plan my 2025 income now to minimize my 2027 Medicare charges. I'm filing single. It seems that no one knows what the ...
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
According to Becker's Review, a leading healthcare publication, Memorial Hospital has the opportunity to announce its ...
Nursing home residents that receive Medicaid benefits may be affected by a change in federal poverty level standards, which are applied to eligibility ...
Obamacare enrollments in health insurance exchanges for the 2025 enrollment period have reached 24.2M, an all-time high. Read ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback